Liver cancer patients can start with lower dose of chemotherapy and live just as long

(University of Pennsylvania School of Medicine) Patients with the most common type of liver cancer who are taking the chemotherapy drug sorafenib can begin their treatment with a lower dose than is currently considered standard, and it will not affect how long they live when compared to patients who start on the full dose.